Digestive System Drugs News

News

Warner Chilcott CEO Discusses 2012 Guidance (Transcript) - Seeking Alpha
seekingalpha.com | Jan 27, 2012
< p > Warner Chilcott plc ( < a href='http://seekingalpha.com/symbol/wcrx' title='Warner Chilcott Limited' > WCRX < /a > ) < /p > < p > 2012 Guidance Call < /p > < p > January 27, 2012 8:00 AM ET < /p > < p > < strong > Executives < /strong > < /p > < p > Paul Herendeen – EVP & amp; CFO < /p > < p

Merck Co Inc Gets Positive CHMP Opinion for
www.biospace.com | Jan 26, 2012
WHITEHOUSE STATION, N.J.---- Positive Opinion Recommends Approval of the First and Only Anti-TNF Therapy in Pediatric Patients with Severely Active

Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 | PRLog
www.prlog.org | Jan 13, 2012
Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The Ankylosing Spondylitis Therapeutics Market is Forecast to Show Moderate Growth until 2019 - PR11771204

United States Joins Whistleblower Case Accusing Par Pharmaceuticals of Nationwide Drug Switching
www.prweb.com | Sep 6, 2011
A leading generic drug distributor, Par Pharmaceuticals, and two foreign companies defrauded government healthcare systems through a nationwide drug switching scheme, alleges a whistleblower lawsuit that became public today when it was unsealed by the federal court in Chicago. According to the

AstraZeneca's NEXIUM receives first regulatory approval in Japan | Pharma Asia
www.pharmaasia.com | Jul 1, 2011
AstraZeneca announced that NEXIUM (esomeprazole magnesium) 10 mg and 20 mg capsules have received regulatory approval in Japan for the treatment of acid-related conditions including non-erosive reflux disease (NERD), reflux esophagitis, and peptic ulcer disease (PUD). NEXIUM also received

Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With
www.abbott.com | Jun 14, 2011
Abbott Receives FDA Approval For CREON & reg; (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis

FT.com / Companies / Healthcare - Reckitt faces £89m NHS lawsuit over Gaviscon
www.ft.com | Apr 17, 2011
The consumer goods group said it will 'vigorously defend' itself against claims, after the OFT fined it for abusing its dominant position by withdrawing the drug

Medical News: Supreme Court to Hear Generic Drug Labeling Case - in Product Alert, Prescriptions
www.medpagetoday.com | Mar 26, 2011
WASHINGTON — The U.S. Supreme Court will hear arguments on Wednesday in a case involving generic drugmakers' responsibility to provide safety information in product labeling.

Misoprostol use in the community to reduce maternal death : The Lancet
www.thelancet.com | Sep 21, 2010
Misoprostol use in the community to reduce maternal death. By - A Metin Gülmezoglu, Matthews Mathai, João Paulo Souza, Catherine d'Arcangues, Michael Mbizvo

Approval of Additional Indications for Helicobacter pylori Eradication by Concomitant Therapy with
www.takeda.com | Jun 18, 2010
Osaka and Tokyo, Japan, June 18, 2010 --- Takeda Pharmaceutical Company Limited (Osaka, President and CEO: Yasuchika Hasegawa), AstraZeneca K.K. (Osaka, President and CEO: Masahiro Kato), Mitsubishi Tanabe Pharma Corporation (Osaka; President and CEO: Michihiro Tsuchiya), and Eisai Co., Ltd.